Αποτελέσματα Αναζήτησης
17 Ιουλ 2024 · The results reflect the risk of PASC among persons who tested positive for SARS-CoV-2 as compared with the control cohort, which included persons with no known infection (no known positive...
6 Ιουλ 2024 · Diagnosis of heart disease, obesity, diabetes, high blood pressure, and kidney or liver disease is linked to the stress of racial discrimination. A person with any of these diseases, due to racism or other causes, has a higher risk of severe illness with COVID-19.
2 Ιουλ 2024 · Clinical presentation. Many people with SARS-CoV-2 infection are asymptomatic 9. Symptoms and signs of COVID-19 are non-specific 1 but in symptomatic individuals most commonly include: fever (85-90%) cough (65-70%) with sputum (30-35%) smell and taste disturbances (50%) 12. fatigue (35-40%) shortness of breath (15-20%) Complications.
11 Ιουλ 2024 · Sero-monitoring provides context to the epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and changes in population immunity following vaccine...
1 Ιουλ 2024 · Immunity against SARS lasted about 2 years after the index infection. Research has found that approximately 95% of individuals are likely to retain immunity 8 months after their initial infection with SARS-CoV-2.
17 Ιουλ 2024 · COMPASS, a population-based cross-sectional serosurvey, enrolled ≈22,000 adults and children from community venues in 15 largely urban US settings in the first half of 2021 and found that the overall prevalence of prior and active SARS-CoV-2 infection was 12.9%.
13 Ιουλ 2024 · Evaluate variables which affected the rate of seropositivity against SARS-CoV-2. Assess the prevalence and clinical implications of positive PCR tests for SARS-CoV-2 in the current study. Analyze study participants’ willingness to receive the COVID-19 vaccine.
